Health Technology Assessment

Indian Economy glossary

Also called: HTA, HTAIn · Topic: Human Capital: Education, Health and Demographic Dividend · NCERT: Beyond NCERT

Meaning

Health Technology Assessment (HTA) is a careful, step-by-step check of a health technology before the government decides to pay for it. A "health technology" here means any medicine, vaccine, test kit, device or treatment method. HTA asks three things: does it work better than what we use now, what does it cost, and how will it affect patients and society? Public money for health is limited, so HTA helps the state spend it on what gives the most health for each rupee. In India this work is done by HTAIn (Health Technology Assessment in India), under the Department of Health Research (DHR).

Example

A state wants to buy a new diagnostic kit for tuberculosis (TB). An HTA study compares it with the test the state already uses. It looks at how many extra TB cases the new kit finds and how much extra it costs for each patient. If the extra benefit is worth the extra cost, the state buys the kit. At ISHTA 2025 (the third International Symposium on HTA, March 2025), an HTA Costing Database was released to give researchers cost data for exactly this kind of comparison.

Don't confuse with

  • Technology transfer: this moves a technology from the lab that developed it to a company, through a licence, so the company can make and sell it. HTA decides whether the public health system should buy and use that product.
  • Clinical trial: a clinical trial tests whether a treatment is safe and works. HTA goes further and also asks whether it gives value for money compared with other options.

Recent developments

  • 2025: The National Health Authority (NHA), which runs Ayushman Bharat PM-JAY, India's public health insurance scheme, renewed its MoU (agreement) with DHR and ICMR. Under it, HTAIn will also assess AI-based digital health tools used under AB-PMJAY. It will check three things: clinical efficacy (does the tool actually improve patients' health), cost-effectiveness (is the benefit worth the money) and equity (do all groups of patients benefit fairly). This matters because HTA now covers software and AI as well as medicines, kits and devices.

Read more